May 12, 2017 — Peripheral artery disease (PAD) patients who were treated with an anti-inflammatory steroid injected ...
April 27, 2017 — Mercator MedSystems Inc. announced the first patient enrollment into the TANGO (Temsirolimus ...
February 15, 2017 — Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE ...
October 7, 2016 — Mercator MedSystems recently announced that 13-month data from the DANCE trial was presented during a ...
August 10, 2016 — Mercator MedSystems Inc. announced the enrollment of the first critical limb ischemia (CLI) patients ...
June 5, 2014 — Mercator MedSystems is in the midst of its prospective, 300-patient, 30-site DANCE (Dexamethasone to the ...
February 28, 2014 — Mercator MedSystems released pilot study data from a single-arm, open label study of 20 patients ...
August 2, 2013 — Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S ...
March 7, 2013 — Mercator MedSystems Inc. announced it has received CE mark approval to market its Cricket and Bullfrog ...
July 16, 2012 — Mercator MedSystems, a medical technology company whose platform Micro-Infusion Catheter technology ...